Brief: Galapagos NV Ends R&D Deal With Ryvu Therapeutics

Ryvu Therapeutics SA

06/04/2023 16:12

April 6 (Reuters) - Ryvu Therapeutics SA  RVU.WA :
    * NOTICE OF TERMINATION REGARDING OPTION, LICENSE AND
COLLABORATION AGREEMENT WITH GALAPAGOS NV
    * FOLLOWING THIS DEAL TERMINATION, GRANTED LICENSE WILL
EXPIRE AMD
RYVU WILL GAIN FULL COPYRIGHT TO ALL MOLECULES AND KNOW-HOW
GIVEN TO GALAPAGOS
    * COMPANY IS NOT OBLIGATED TO PAY ANY REMUNERATION OR TO
REFUND
ANY SUMS OBTAINED FROM GALAPAGOS UNDER PREVIOUSLY SIGNED DEAL

Source text for Eikon:  ID:nEM6Xh3kBa 
Further company coverage:  RVU.WA 

 (Reporting by Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))